Kılıçaslan, N. A. Et Al. 2022. Dasatinib-related pleural effusion and lymphocytosis rates are different between adult and pediatric patients with Philadelphia chromosome-positive leukemias: Are age and comorbidities only to blame?. Expert review of respiratory medicine , vol.16 , 849-852.

Kılıçaslan, N. A., Börekçi, Ş., Özdemir, G. N., Sayitoğlu, M., & Eşkazan, A. E., (2022). Dasatinib-related pleural effusion and lymphocytosis rates are different between adult and pediatric patients with Philadelphia chromosome-positive leukemias: Are age and comorbidities only to blame?. Expert review of respiratory medicine , vol.16, 849-852.

Kılıçaslan, Necati Et Al. "Dasatinib-related pleural effusion and lymphocytosis rates are different between adult and pediatric patients with Philadelphia chromosome-positive leukemias: Are age and comorbidities only to blame?," Expert review of respiratory medicine , vol.16, 849-852, 2022

Kılıçaslan, Necati A. Et Al. "Dasatinib-related pleural effusion and lymphocytosis rates are different between adult and pediatric patients with Philadelphia chromosome-positive leukemias: Are age and comorbidities only to blame?." Expert review of respiratory medicine , vol.16, pp.849-852, 2022

Kılıçaslan, N. A. Et Al. (2022) . "Dasatinib-related pleural effusion and lymphocytosis rates are different between adult and pediatric patients with Philadelphia chromosome-positive leukemias: Are age and comorbidities only to blame?." Expert review of respiratory medicine , vol.16, pp.849-852.

@article{article, author={Necati Alp Kılıçaslan Et Al. }, title={Dasatinib-related pleural effusion and lymphocytosis rates are different between adult and pediatric patients with Philadelphia chromosome-positive leukemias: Are age and comorbidities only to blame?}, journal={Expert review of respiratory medicine}, year=2022, pages={849-852} }